Hubbes M, D'Agrosa R M, Callahan J W
Research Institute, Hospital For Sick Children, Toronto, Ontario, Canada.
Biochem J. 1992 Aug 1;285 ( Pt 3)(Pt 3):827-31. doi: 10.1042/bj2850827.
GM1 ganglioside beta-galactosidase (beta-Gal) is deficient in the autosomal recessive disorder GM1 gangliosidosis. A portion of the enzyme occurs in a complex with neuraminidase and an additional glycoprotein, protective protein, but the nature of the interactions conferring the stability of the complex is unknown. Affinity chromatography of beta-Gal on p-aminophenylthiogalactose-Sepharose (PATG-Sepharose) at pH 4.3, the pH optimum of beta-Gal, resulted in a 260-fold enrichment of beta-Gal, but the major protein in the fraction had an M(r) value of 74,000. Affinity chromatography on PATG-Sepharose at pH 5.2 showed substantial enrichment (4000-fold) of beta-Gal, and the mature form of the enzyme (M(r) 64,000) was the major protein in the preparation. Using h.p.l.c. molecular-sieve chromatography, we found that about 15% of the total beta-Gal occurred in a high-M(r) form (greater than 600,000), the presumptive complex, with 85% eluting at M(r) 150,000, suggestive of a dimer. This distribution was independent of both high (60 mg/ml) and low (5 mg/ml) protein concentration and the pH (pH 4.3 or 5.2) of the sample applied to the column. Furthermore, incubation for 90 min at 37 degrees C, conditions which had previously been suggested as optimal for formation of the complex, had no effect on this distribution. Further fractionation by anion-exchange chromatography and a second affinity column step yielded a beta-Gal preparation that contained a single polypeptide chain (M(r) 64,000), was devoid of neuraminidase and protective protein (absent carboxypeptidase activity), and when injected into rabbits gave rise to monospecific rabbit antisera. We conclude that the protein composition of the complex is variable (i.e. it is different when isolated at pH 4.3 and 5.2) and that the amount of beta-Gal tightly associated with the complex constitutes a small fraction of the total beta-Gal activity. The more prevalent form of the enzyme is a beta-Gal homodimer that is stable and devoid of either neuraminidase activity or protective protein.
GM1神经节苷脂β-半乳糖苷酶(β-Gal)在常染色体隐性疾病GM1神经节苷脂贮积症中缺乏。该酶的一部分与神经氨酸酶和另一种糖蛋白(保护蛋白)形成复合物,但赋予该复合物稳定性的相互作用的本质尚不清楚。在β-Gal的最适pH值4.3下,β-Gal在对氨基苯硫代半乳糖-琼脂糖(PATG-琼脂糖)上进行亲和层析,使β-Gal富集了260倍,但该组分中的主要蛋白质的相对分子质量(M(r))为74,000。在pH 5.2下于PATG-琼脂糖上进行亲和层析显示β-Gal有大量富集(4000倍),并且该酶的成熟形式(M(r) 64,000)是制剂中的主要蛋白质。使用高效液相色谱分子筛层析,我们发现总β-Gal中约15%以高M(r)形式(大于600,000)存在,即推测的复合物,85%在M(r) 150,000处洗脱,提示为二聚体。这种分布与高(60 mg/ml)和低(5 mg/ml)蛋白质浓度以及应用于柱的样品的pH值(pH 4.3或5.2)均无关。此外,在37℃孵育90分钟(此前曾被认为是形成复合物的最佳条件)对这种分布没有影响。通过阴离子交换层析和第二步亲和柱步骤进一步分级分离得到一种β-Gal制剂,其包含一条单一多肽链(M(r) 64,000),不含神经氨酸酶和保护蛋白(缺乏羧肽酶活性),并且当注射到兔子体内时产生单特异性兔抗血清。我们得出结论,该复合物的蛋白质组成是可变的(即在pH 4.3和5.